{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T11:51:10Z","timestamp":1659354670422},"reference-count":9,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2017,3,4]]},"DOI":"10.1080\/14656566.2017.1293653","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T04:04:15Z","timestamp":1486958655000},"page":"455-455","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1080","volume":"18","author":[{"given":"Ismail","family":"Kocyigit","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Erciyes University School of Medicine, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eray","family":"Eroglu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Erciyes University School of Medicine, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tevfik","family":"Ecder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, Istanbul Bilim University School of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1232394"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0475-x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2010.01.001"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2174\/1573402111309010002"},{"issue":"5","key":"CIT0005","first-page":"647","volume":"3","author":"Veverka A","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1020790"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.05.066"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00327.2014"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60614-0"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2017.1293653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T06:06:01Z","timestamp":1500530761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2017.1293653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,20]]},"published-print":{"date-parts":[[2017,3,4]]}},"alternative-id":["10.1080\/14656566.2017.1293653"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2017.1293653","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}